Jubilant HollisterStier enters into agreement of $149.6 mn with US Govt to expand critical vaccine manufacturing capacity
This agreement is in addition to the $92 million filling line expansion announced in November 2021
This agreement is in addition to the $92 million filling line expansion announced in November 2021
The product will be launched by NATCO's commercial partner Viatris.
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
Already an existing partner and supplier of ingredients to Medisca, striking this agreement with SUANFARMA involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The integration and transition of the brands are expected to be completed by June 2022.
Bempedoic acid helps lower cardiovascular risk in high or very high-risk atherosclerotic cardiovascular disease (ASCVD) patients as an add-on therapy to maximally tolerated statin and/or ezetimibe
Subscribe To Our Newsletter & Stay Updated